Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 4, 1999, Pages 515-523

  Langan, C E ^a   Zuck, P ^b   Vogel, F ^c   McIvor, A ^d   Pierzchala, W ^e   Smakal, M ^f   Staley, H ^g   Marr, C ^g  

^a Baillieston Health Centre   (United Kingdom)

^b Bon Secours Hospital   (France)

^c Kliniken des Main Taunus Kreises   (Germany)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e Katerda i Klinika Pneumonologii SLAM   (Poland)

^f Ke Stacirne 608 ^*  (Czech Republic)

^g GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; GREPAFLOXACIN;

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CLINICAL TRIAL; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TASTE DISORDER; TIME; TREATMENT OUTCOME; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; BRONCHITIS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; PIPERAZINES;

EID: 0032869642     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.4.515     Document Type: Article

References (24)

1. Ball, P. & Make, B. (1998). Acute exacerbations of chronic bronchitis - an international comparison. Chest 113, S199-204.
2. Anthonisen, N. R., Manfreda, J., Warren, C. P., Hershfield, E. S., Harding, G. K. & Nelson, N. A. (1987). Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine 106, 196-204.
3. Gump, D. W., Phillips, C. A., Forsyth, B. R., McIntosh, K., Lamborn, K. R. & Stouch, W. H. (1976). Role of infection in chronic bronchitis. American Review of Respiratory Disease 113, 465-74.
4. Kayser, F. H. (1992). Changes in the spectrum of organisms causing respiratory tract infections: a review. Postgraduate Medical Journal 68, Suppl. 3, S17-23.
5. Saint, S., Bent, S., Vittinghoff, E. & Grady, D. (1995). Antibiotics in chronic obstructive pulmonary disease exacerbations - a metaanalysis. Journal of the American Medical Association 273, 957-60.
6. Ball, P. (1996). Infective pathogenesis and outcomes in chronic bronchitis. Current Opinion in Pulmonary Medicine 2, 181-5.
7. Goldsmith, C. E., Moore, J. E. & Murphy, P. G. (1997). Pneumococcal resistance in the UK. Journal of Antimicrobial Chemotherapy 40, Suppl. A, 11-8.
8. Thornsberry, C., Ogilvic, P., Mauriz, Y. & Kahn, J. (1997). Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1996-7 respiratory season. Diagnostic Microbiology and Infectious Disease 29, 249-57.
9. Imada, T., Miyazaki, S., Nishida, M., Yamaguchi, K. & Goto, S. (1992). In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116. Antimicrobial Agents and Chemotherapy 36, 573-9.
10. Marco, F., Jones, R. N., Hoban, D. J., Pignatari, A. C., Yamane, N. & Frei, R. (1994). In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study. Journal of Antimicrobial Chemotherapy 33, 647-54.
11. Cook, P. J., Andrews, J. M., Wise, R., Honeybourne, D. & Moudgil, H. (1995). Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments. Journal of Antimicrobial Chemotherapy 35, 317-26.
12. Efthymiopoulos, C., Bramer, S. L. & Maroli, A. (1997). Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males. Clinical Pharmacokinetics 33, Suppl. 1, 1-8.
13. Cramerm, J. A. (1998). Enhancing patient compliance in the elderly. Role of packaging aids and monitoring. Drugs and Aging 12, 7-15.
14. Eisenm, S. A., Millerm, D. K., Woodward, R. S., Spitznagel, E. & Przybeck, T. R. (1990). The effect of prescribed daily dose frequency on patient medication compliance. Archives of Internal Medicine 150, 1881-4.
15. Chodosh, S., Lakshminarayan, S., Swarz, H. & Breisch, S. (1998). Efficacy and safety of a 10 day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10 day course of 500 milligrams of ciprofloxacin twice daily. Antimicrobial Agents and Chemotherapy 42, 114-20.
16. Langan, C. E., Cranfield, R., Breisch, S. & Pettit, R. (1997). Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 40, Suppl. A, 63-72.
17. Ikeda, A., Nishimura, K. & Izumi, T. (1998). Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease. Drugs and Aging 12, 129-37.
18. Langan, C., Clecner, B., Cazzola, C. M., Brambilla, C. Y., Holmes, C. & Staley, H. (1998). Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis. International Journal of Clinical Practice 52, 289-97.
19. Peters, D. & Clissold, S. (1992). Clarithromycin: a review of its antimicrobial activity. Pharmacokinetic Properties and Therapeutic Potential 44, 117-64.
20. DeAbate, C. A., Bettis, R., Munk, Z. M., Fleming, H., Munn, N. J., Riffer, E. et al. (1999). Effectivenes of short course therapy (5 day) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. Clinical Therapeutics 21, 172-88.
21. DeAbate, C., Myers, D., Henry, D., Upchurch, J., Lecara, G., Giguere, G. et al. (1999). Comparative safety and efficacy of once-daily grepafloxacin in the treatment of ABECB. Clinical Drug Investigation 17, 1-31.
22. O'Doherty, B., Dutchman, D. A., Pettit, R. & Maroli, A. (1997). Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. Journal of Antimicrobial Chemotherapy 40, Suppl. A, 73-61.
23. Wandstrat, T. L. & Kaplan, B. (1997). Pharmacoeconomic impact of factors affecting compliance with antibiotic regimens in the treatment of acute otitis media. Pediatric Infectious Disease Journal 16, S27-9.
24. Sclar, D. A., Tartaglione, T. A. & Fine, M. J. (1994). Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases. Infectious Agents and Disease 3, 266-73.